Literature DB >> 3315614

Consequences of antibody binding in vitro on the pharmacological properties of anisoylated plasminogen streptokinase activator complex.

R Fears1, H Ferres, M Hibbs, R Standring.   

Abstract

Mesh:

Substances:

Year:  1987        PMID: 3315614     DOI: 10.2165/00003495-198700333-00008

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


× No keyword cloud information.
  7 in total

1.  Immunological and biochemical comparison of streptokinase and the streptokinase plasminogen complex.

Authors:  G H Barlow; E Devine; R Finley
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1975-03

2.  The clearance of heterologous protein from the circulation of normal and immunized man.

Authors:  A P FLETCHER; N ALKJAERSIG; S SHERRY
Journal:  J Clin Invest       Date:  1958-09       Impact factor: 14.808

3.  The fibrin plate method for estimating fibrinolytic activity.

Authors:  T ASTRUP; S MULLERTZ
Journal:  Arch Biochem Biophys       Date:  1952-10       Impact factor: 4.013

4.  Coronary thrombolysis with clot-selective plasminogen activators.

Authors:  D Collen; H Bounameaux
Journal:  Herz       Date:  1986-02       Impact factor: 1.443

5.  Deacylation studies in vitro on anisoylated plasminogen streptokinase activator complex.

Authors:  H Ferres; M Hibbs; R A Smith
Journal:  Drugs       Date:  1987       Impact factor: 9.546

6.  Assessment of anti-streptokinase antibody levels in human sera using a microradioimmunoassay procedure.

Authors:  D M Moran; R Standring; E A Lavender; G S Harris
Journal:  Thromb Haemost       Date:  1984-12-29       Impact factor: 5.249

7.  Clinical failure of streptokinase due to an unsuspected high titer of antistreptokinase antibody.

Authors:  A S Lew; T Neer; L Rodriguez; I L Geft; P K Shah; W Ganz
Journal:  J Am Coll Cardiol       Date:  1984-07       Impact factor: 24.094

  7 in total
  2 in total

1.  Monitoring of streptokinase resistance titre in acute myocardial infarction patients up to 30 months after giving streptokinase or anistreplase and related studies to measure specific antistreptokinase IgG.

Authors:  R Fears; H Ferres; E Glasgow; R Standring; K J Hogg; J D Gemmill; J M Burns; A P Rae; F G Dunn; W S Hillis
Journal:  Br Heart J       Date:  1992-08

2.  The significance of anti-streptokinase antibodies.

Authors:  M Lynch; B L Pentecost; W A Littler; R A Stockley
Journal:  Clin Exp Immunol       Date:  1994-06       Impact factor: 4.330

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.